ArticleBiophysical journal2026
Chemotaxis kinase CheA is regulated by modulating interdomain interactions.
Article in Biophysical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Activation of the chemotaxis kinase CheA, controlled by ligand binding or covalent modification of its associated chemoreceptor, modulates the chemotaxis behavior of bacteria such as Escherichia coli. The activation of CheA, which results in large changes to its autophosphorylation rate, is proposed to involve control of interdomain interactions between the catalytic P4 domain and the substrate P1 domain. While both productive and nonproductive interdomain P1/P4 interactions have been identified and modeled, observation of how these interdomain interactions impact activity has not been determined in functional signaling complexes. Here, we report evidence for changes to CheA P1/P4 interactions upon activation based on changes in chemical shift perturbations of NMR resonances of isolated CheA-P1 domains upon addition of signaling complexes of CheA-P3P4P5, chemoreceptor cytoplasmic fragments, and CheW. We found that CheA-P1 interacts nonproductively with CheA-P4 in kinase-off complexes and forms P1/P1' dimers during this interaction. In contrast, P1 domains in free CheA do not form an observable population of P1/P1' dimers during their nonproductive P1/P4 interaction, so incorporation of CheA into signaling complexes must induce conformational changes to the P4 domain that allow for P1/P1' dimerization and could further stabilize the nonproductive interaction. Activation of CheA in signaling complexes leads to higher affinity interactions between P1 and P4 domains in a productive mode that could lead to higher autophosphorylation activity. The presence of AMPPCP, an ATP analog, focuses the productive interaction into a more specific binding mode that could be necessary for catalysis. Thus, the activation of CheA in signaling complexes is controlled by changes to the P4 domain that control the transient interactions of P1 and P4 domains. Loss of the nonproductive interdomain interaction happens simultaneously with the gain of the high-affinity productive interdomain interaction to activate the kinase CheA.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.